CRYSTAL HOOYMAN: Open Payments
NPI 1356176812 · GREEN BAY, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,643 in 150 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,182 · 2025 $2,643
Food & beverage: $2,643
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $420 |
| Alkermes, Inc. | 21 | $361 |
| Neurocrine BioSciences, Inc. | 17 | $325 |
| Otsuka America Pharmaceutical, Inc. | 15 | $324 |
| ABBVIE INC. | 16 | $279 |
| Axsome Therapeutics, Inc. | 20 | $255 |
| Lundbeck LLC | 10 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Collegium Pharmaceutical, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
Products named: COBENFY, INGREZZA, ABILIFY MAINTENA, Auvelity, REXULTI, ARISTADA, VRAYLAR, LYBALVI.
Industry payments across WI — which companies pay providers there.
